©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 114607
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.114607
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.114607
Table 6 Comparison of survival between groups, n (%)
| Survival indicator | Nutritional risk group (n = 37) | Non-nutritional risk group (n = 43) | χ² | P value |
| Disease progression | 17 (45.9) | 7 (16.3) | 8.973 | 0.003 |
| Local recurrence | 6 (16.2) | 3 (7.0) | ||
| Distant metastasis | 11 (29.7) | 4 (9.3) | ||
| Death | 10 (27.0) | 4 (9.3) | 4.589 | 0.032 |
| Median DFS (months, 95%CI) | Not reached | Not reached | 5.573 | 0.018 |
| 3-year DFS rate (%) | 62.1 | 83.7 | ||
| Median OS (months, 95%CI) | Not reached | Not reached | 5.234 | 0.023 |
| 3-year OS rate (%) | 72.4 | 90.7 |
- Citation: Zhou K, Tu RF, Lu LH, Zhang H. Impact of nutritional status on treatment completion and prognosis during adjuvant chemotherapy following gastric cancer surgery. World J Gastrointest Surg 2026; 18(2): 114607
- URL: https://www.wjgnet.com/1948-9366/full/v18/i2/114607.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i2.114607